Molecular Diagnostics Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Molecular Diagnostics Market is projected to grow from USD 23.41 billion in 2022 to USD 31.24 billion at a CAGR value of 5.8% from 2022 to 2027. The major drivers of the molecular diagnostics market are the growing incidence of infectious diseases and genetic disorders among the population, increasing investment in the adoption of molecular diagnostic tests, advancements in testing techniques such as ddPCR, and the growing applicability of molecular diagnostic tests.
Browse 155 Market Data Tables and 133 Figures spread through 156 Pages and in-depth TOC on “Global Molecular Diagnostics Market Forecast to 2027’’ https://www.globalmarketestimates.com/market-report/molecular-diagnostics-market-3792
By Product (Instruments, Consumables), By Technology (PCR [Standard PCR, rtPCR], In Situ Hybridization, Chips & Microarrays, Mass Spectrometry (MS), Sequencing), By Application (Infectious Disease [COVID-19, Methicillin-resistant Staphylococcus Aureus (MRSA), Clostridium Difficile, Vancomycin-resistant Enterococci (VRE), Carbapenem-resistant Bacteria, Flu, Respiratory Syncytial Virus (RSV), Candida, Tuberculosis & Drug-resistant TB, Meningitis, Gastrointestinal Panel Testing, Chlamydia, Gonorrhea, HIV, Hepatitis C, Hepatitis B], Oncology [Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Blood Cancer, Lung Cancer], Neurological Disease, Cardiovascular Disease), By End-User (Hospitals & Clinics, Laboratories, Diagnostic Centers, Home Testing), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis
Key Market Insights
As per the technology outlook, the PCR segment is expected to be the largest segment in the molecular diagnostics market from 2022 to 2027 The Asia Pacific region is analyzed to be the fastest-growing segment in the market As per the application outlook, the oncology segment is expected to be the largest segment in the molecular diagnostics market from 2022 to 2027
North America (the United States, Canada, and Mexico) will have a dominant share in the global Molecular Diagnostics market from 2022 to 2027
Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, bioMérieux SA, Laboratory Corporation of America, Quest Diagnostics, Hologic, Inc., Abbott, Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., DiaSorin Company, Beckman Coulter Inc., BioFire Defense, LLC, CoDiagnostics, Inc., Sysmex Corporation, Johnson & Johnson Services, Inc., Hologic Corporation, Illumina Ltd., PCR Biosystems, PCR-Dx, Curiosity Diagnostic, Genome Diagnostics Pvt. Ltd., Molbio Diagnostics Pvt. Ltd., 1drop Inc., Exact Sciences Laboratories, LumiraDx UK Ltd., and Sherlock BioSciences, Inc., among others, are the some of the key players in the molecular diagnostics market
Product Outlook (Revenue, USD Billion, 2022-2027)
Instruments
Consumables
Technology Size Outlook (Revenue, USD Billion, 2022-2027)
PCR
Standard PCR
rtPCR
Others
In Situ Hybridization
Chips and Microarrays
Mass Spectrometry (MS)
Sequencing
Other Technologies
Application Size Outlook (Revenue, USD Billion, 2022-2027)
Infectious Disease
COVID-19
Methicillin-resistant Staphylococcus Aureus (MRSA)
Clostridium Difficile
Vancomycin-resistant Enterococci (VRE)
Carbapenem-resistant Bacteria
Flu
Respiratory Syncytial Virus (RSV)
Candida
Tuberculosis and Drug-resistant TB
Meningitis
Gastrointestinal Panel Testing
Chlamydia
Gonorrhea
HIV
Hepatitis C
Hepatitis B
Other Infectious Disease
Breast Cancer
Prostate Cancer
Colorectal Cancer
Cervical Cancer
Kidney Cancer
Liver Cancer
Blood Cancer
Lung Cancer
Other Cancer
Oncology
Neurological Disease
Cardiovascular Disease
Others
End-User Outlook (Revenue, USD Billion, 2022-2027)
Hospitals & Clinics
Diagnostic Centers
Home Testing
Others
Regional Outlook (Revenue, USD Billion, 2022-2027) North America
The U.S. Canada Mexico
Europe
Germany UK France Spain Italy Rest of Europe
Asia Pacific
China India Japan South Korea Australia Rest of APAC
Central & South America
Brazil Argentina Rest of CSA
Middle East & Africa
Saudi Arabia UAE Rest of MEA
Contact: Yash Jain Email address: yash.jain@globalmarketestimates.com Phone Number: +1 6026667238